Systemic lupus erythematosus (SLE) is the prototypic systemic autoimmune disorder. With highly variable clinical manifestations and only 4 out of 11 criteria required to establish the diagnosis ( 1 ), multiple pathogenic pathways are likely to contribute to end-organ damage in this disease. Elucidating the diff erent pathways that lead to lupus in particular subsets of patients and identifying biomarkers that fl ag the diff erent pathways is essential to design more specific and effective therapies.
The formation of autoantibodies against cell nuclear components, including double-stranded DNA (dsDNA), ribonuclear proteins, and histones, is a consistent feature and therefore likely to be fundamental to the disease. This is supported by the observation that formation of autoantibodies precedes development of clinical manifestations of lupus ( 2 ) , evidence that some of these antibodies contribute to end-organ damage, and the effi cacy of B cell -depleting therapy with rituximab ( 3 ) . Identifi cation of defects that result in autoantibody formation is therefore of considerable importance in understanding the pathogenesis of lupus.
Numerous engineered and spontaneous defects in central and peripheral tolerance result in antinuclear antibodies (ANAs). However, the specifi city and high affi nity of the autoantibody response in lupus points to a defect in the response to self-antigen in the periphery. During T-dependent responses, activated B cells receive help from T cells in the T cell zones of secondary lymphoid tissues, and diff erentiate either extrafollicularly into short-lived plasma cells that produce low-affi nity antibody, or enter the follicular largely driven by B cell -extrinsic factors ( 22 ) . Roquin san/san mice have a marked accumulation of T cells within the B cell follicles, and the T FH subset is overrepresented within the CD4 + cell compartment.
In this paper, we report that dysregulation of the GC response through excessive formation of T FH cells is responsible for autoimmunity in Roquin san/san mice. Loss of one allele of Bcl6 , the master transcriptional regulator of GCs ( 25, 26 ) , signifi cantly reduces spontaneous GC formation in Roquin san/san mice and the lupus phenotype. Furthermore, deletion of Sap ( Sh2d1a ) from Roquin san/san mice causes a dramatic reduction of T FH cells and IL-21. Sap is a small adaptor protein necessary for signaling through the signaling lymphocyte activation molecule family cell-surface receptors that regulates signals downstream of the TCR. Roquin san/san Sap Ϫ / Ϫ CD4 + cells also express lower levels of ICOS than Roquin san/san Sap +/+ cells. This results in abrogation of ANAs (including anti-dsDNA) and end-stage renal disease. These fi ndings establish a causal pathway from the san allele of Roquin to excess T FH formation, aberrant GC formation, and positive selection of pathogenic high-affi nity autoantibodies to illuminate a novel pathway of lupus pathogenesis.
RESULTS

Heterozygous Bcl6 defi ciency reduces spontaneous GCs
and attenuates autoimmunity in Roquin san/san mice BCL6 has been shown to be the master transcriptional regulator of GC B cells ( 27 ) . As BCL6 defi ciency results in early mortality because of widespread infl ammation, we investigated Bcl6 +/ Ϫ mice for possible defects in the GC response. 8 d after sheep red blood cell (SRBC) immunization, the percentage of GC cells was more than fi vefold lower in mice heterozygous for Bcl6 defi ciency (2.3 ± 0.59% vs. 0.43 ± 0.46%; P = 0.0011; Fig. 1 a ) .
To determine whether Bcl6 heterozygosity could curtail the spontaneous GC response in Roquin san/san mice, we compared the percentage of GC cells in unimmunized Roquin san/san Bcl6 +/+ and Roquin san/san Bcl6 +/ Ϫ mice. As seen in wild-type mice, loss of one allele of Bcl6 caused a twofold reduction (4.4 ± 1.9% vs. 2.1 ± 0.5%; P = 0.0026) in the percentage of spontaneous GCs in Roquin san/san mice ( Fig. 1 b ) . Loss of one allele of Bcl-6 also reduced GC B cells after SRBC immunization in a cell-autonomous manner (Fig. S1 , available at http://www .jem.org/cgi/content/full/jem.20081886/DC1).
We then tested whether reduction in the spontaneous GC response in Roquin san/san Bcl6 +/ Ϫ mice was accompanied by reduced pathology. Serum dsDNA antibodies were present in 50% of Roquin san/san Bcl6 +/ Ϫ mice tested compared with 100% of Roquin san/san Bcl6 +/+ mice ( Fig. 1 c ) . Kidney pathology was also signifi cantly reduced in Roquin san/san Bcl6 +/ Ϫ mice ( Fig. 1, d and e ).
The lupus-like pathology of Roquin san/san mice requires T cell activation
We have previously demonstrated that Roquin acts predominantly B cell extrinsically to induce spontaneous GC formation, pathway and form germinal centers (GCs) ( 4 ) . Within this microenvironment, B cells undergo somatic hypermutation (SHM) and isotype switching, resulting in the generation of memory B cells and long-lived plasma cells that secrete highaffi nity antigen-specifi c IgG antibodies ( 5, 6 ) . Selection of mutated high-affi nity GC B cells depends on restimulation with antigen arrayed on follicular dendritic cells and provision of help by follicular T helper (T FH ) cells.
Because SHM has the potential to generate self-reactive antibodies ( 7 ), it has been long thought that aberrant selection within GCs represents a candidate pathway to the production of lupus-associated autoantibodies. Indeed, autoantibodies detected in SLE patients and mouse lupus models are generally high affi nity and somatically mutated ( 7, 8 ) . Exclusion of selfreactive B cells from GCs has been shown to be defective in SLE patients. Also, GCs have been shown to form spontaneously in several diff erent mouse models of lupus ( 9 ) , and these are rich in apoptotic cells displaying the antigenic targets of lupus autoimmunity ( 10, 11 ) . Although SHM can occur outside GCs, this process is far less effi cient ( 12, 13 ) . Despite all of this circumstantial evidence, there is to date no defi nite proof that GCs and/or T FH cells are directly required for the production of lupus autoantibodies or end-organ damage. In contrast, extrafollicular affi nity maturation of autoantibodies to dsDNA in MRL lpr mice ( 14, 15 ) and T-independent B cell activating factor of the TNF family -driven pathways to lupus have been demonstrated ( 16, 17 ) .
Furthermore, the prevailing model is that within GCs, autoantibodies might arise because of defects in negative rather than positive selection, because GC B cells are programmed to undergo apoptosis by default if they do not receive T cell selection signals. This is consistent with evidence that centrocytes down-regulate apoptosis inhibitors such as Bcl-2 and Bcl-xL while up-regulating proapoptotic molecules such as Fas and Bim ( 18 ) . Normally, a dedicated population of T FH cells is thought to provide help during selection of GC B cells ( 19, 20 ) , and indeed a correlation between increased numbers of T FH cells and autoimmunity has been described in mouse models of lupus ( 21, 22 ) , suggesting that defects in positive selection by T FH cells might indeed lead to lupus. Although recent evidence has suggested that Th17 cells may be responsible for aberrant selection of self-reactive GC B cells and autoantibody formation in BXD2 mice ( 23 ) , direct evidence that T FH cells can drive autoimmunity has not been provided.
The sanroque strain was discovered from screening an ENU mutagenized mouse library for autoimmune regulators ( 24 ) , and exhibits a lupus-like phenotype characterized by highaffi nity anti-dsDNA antibodies, hypergammaglobulinemia, lymphanedopathy, splenomegaly, autoimmune thrombocytopenia, and glomerulonephritis with IgG-containing immune complex deposits. Both the autoimmunity and cellular characteristics of sanroque segregate with homozygosity for the san allele (M 199 R substitution) of Roquin ( Roquin san/san ) ( 22 ) . Roquin has been demonstrated to be a regulator of the stability T cell messenger RNAs. Development of autoimmunity in Roquin san/san mice also correlates with spontaneous GC formation, which is and T cell intrinsically to prevent accumulation of activated/ memory T cells and repress ICOS expression ( 22, 28 ) . These fi ndings suggest that the spontaneous GC reaction is driven by Roquin-mediated dysregulation of T cells. In a fi rst attempt to confi rm that Roquin san/san lupus is T cell driven, we generated Roquin san/san mice defi cient in the major T cell co-stimulator CD28 ( Cd28 Ϫ / Ϫ mice). Failure to prime T cells in Roquin san/san Cd28 Ϫ / Ϫ mice abrogated the production of antinuclear IgG, including high-affi nity anti-dsDNA antibodies ( Fig. 2 a ) . Both interstitial nephritis and glomerular pathology, characterized by increased mesangial cellularity and dense deposits observed in 6-mo-old Roquin san/san mice, were substantially reduced in agematched Roquin san/san Cd28 Ϫ / Ϫ mice, with only very mild interstitial nephritis ( Fig. 2, b and c ) . Less than half of the Roquin san/san Cd28 Ϫ / Ϫ mice examined had low-grade mesangial immune complex deposits ( Fig. 2 c ) . Of note, Roquin san/san Cd28 Ϫ / Ϫ naive CD4 + T cells had a twofold decrease in ICOS expression ( 29 ( 30 ) , are expanded in Roquin san/san mice, we analyzed the percentage and total number of these cells in unimmunized mice and found more than a threefold increase of this subset in Roquin san/san mice compared with littermate controls ( Fig. 2 d ) Fig. 2 e ) . This indicates that Roquin acts in T cells to repress the formation and/or survival of T FH cells. Consistent with the observed increase in T FH cell numbers, IL-21 production was more than twofold higher in splenocyte cultures from Roquin san/san mice ( Fig. 2 f ) .
Although T FH cells are expanded in Roquin san/san mice, it was important to exclude defects in other T cell subsets implicated in autoimmunity. CD4 + CD25 + FoxP3 + T reg cells have been shown to play a role in the regulation of lupus-associated autoantibodies ( 31 ( 31 ) , and recent work suggests that they may be critical to maintain the spontaneous GCs of BXD2 mice ( 23 ) .
To test whether Th17 cell activity is dysregulated in Roquin san/san mice, we analyzed IL-17 levels in splenocyte cell cultures after activation with PMA and ionomycin. IL-17 was detected at comparable levels in cultures from Roquin +/+ and Roquin san/san mice (Fig. S2 b) . In contrast, IL-21, a cytokine secreted by both T FH and Th17 cells ( 33, 34 ) , was found at signifi cantly higher levels in Roquin san/san splenocyte cultures ( Fig. 2 f ) . Collectively these data indicate that the T FH subset in Roquin san/san mice is expanded in a cell-autonomous manner, whereas T reg and Th17 cells do not appear to be dysregulated in a way that has been previously described to result in autoimmunity.
SAP-defi cient mice form reduced numbers of T FH cells
Having established that Roquin acts T cell intrinsically to dysregulate T FH cell numbers leading to the formation of abundant GCs, we hypothesized that disrupting the GC reaction through selective reduction of T FH cell numbers or function would attenuate systemic autoimmunity. SAP is an adaptor protein necessary for signaling through the signaling lymphocyte activation molecule family receptors that regulates signals downstream of the TCR. Mice lacking SAP cannot form GCs or generate immunological memory after immunization, a result of impaired CD4 + T cell help to GC B cells after antigen exposure ( 35 -38 ) . To date, it is not known whether SAP signaling is also required to maintain optimal T FH cell numbers. We enumerated CD4 + CXCR5 + PD-1 high T FH cells in SAPdefi cient unimmunized mice and wild-type littermates, and observed a twofold decrease in the number of basal T FH cells ( Fig. 3 a , left) . This was accompanied by a fourfold reduction in the number of background GC B cells ( Fig. 3 b , right) .
Roquin san/san Sap ؊ / ؊ mice do not form excessive T FH cells or spontaneous GCs Once we had established that SAP defi ciency not only impairs CD4 + T cell help for GC B cells but also decreases T FH cell numbers, we generated Roquin san/san Sap Ϫ / Ϫ mice to determine whether numerically and functionally defective T FH cells in Roquin san/san mice could abrogate the spontaneous GC reactions. As observed in SAP-defi cient mice, loss of SAP in Roquin san/san mice also had an eff ect on T FH cell numbers: there was a fourfold reduction (0.94 ± 0.41% vs. 3.59 ± 1.99%) in the percentage of T FH cells in Roquin san/san Sap Ϫ / Ϫ mice relative to Roquin san/san mice (P = 0.0056; Fig. 3 a , middle). SAP deficiency also resulted in a 10-fold reduction in the percentage of GC B cells in Roquin san/san mice (4.27 ± 1.93% vs. 0.43 ± 0.23%; P = 0.0007; Fig. 3 b , middle). Immunohistochemistry paralleled the fl ow cytometry data, showing reduced size and number of GCs, and a reduction of T cell numbers within PNApositive follicles ( Fig. 3 c ) . These fi ndings indicate that loss of SAP corrects the aberrant formation of T FH cells and the inappropriate GC reaction phenotype of Roquin san/san to levels comparable to Roquin +/+ mice.
To test whether loss of SAP alters other T eff ector subsets in sanroque mice, we quantifi ed Th1 and Th2 cells by fl ow cytometric staining for Tbet and Gata3, respectively. There were no statistically signifi cant diff erences in the percentage of CD44 high GATA3 + CD4 + cells (0.91 ± 0.14% vs. 1.15 ± 0.41%; P = 0.18) or CD44 high Tbet + CD4 + cells (6.76 ± 10.6% vs. 8.66 ± 5.74%; P = 0.59) between Roquin san/san Sap +/+ and Roquin san/san Sap Ϫ / Ϫ mice in peripheral blood ( Fig. 4, a and b ) . Lymph node CD44 high GATA3 + CD4 + cells (2.11 ± 1.68% vs. 1.59 ± 0.81%; P = 0.54) and CD44 high Tbet + CD4 + cells (2.89 ± 1.9% vs. 2.02 ± 0.64%; P = 0.25) between Roquin san/san Sap +/+ and Roquin san/san Sap Ϫ / Ϫ mice were slightly reduced, but these differences were not statistically signifi cant ( Fig. 4 c ) . In contrast, SAP defi ciency caused an approximately fourfold reduction in Roquin san/san lymph node T FH cells (3.93 ± 0.47% vs. 1.11 ± 0.38%; P = 0.001; Fig. 4 ( Fig. 4 d ) . Adoptive transfer of Roquin san/san T FH cells resulted in a threefold increase in the number of GC B cells compared with control mice injected with PBS alone (P = 0.003; Fig. 4 , e and f ). A small increase in the percentage of GC cells was also observed in the mice that received non-T FH eff ector cells, although this was not statistically signifi cant ( Fig. 4, e and f ) . These data suggest that Roquin san/san T FH cells can drive a GC reaction in the absence of exogenous antigen.
SAP defi ciency abrogates the lupus-like phenotype of Roquin san/san mice
Having established that SAP defi ciency prevents T FH cell accumulation and selectively impairs GC responses, we sought to determine whether SAP defi ciency aff ects the serum autoantibodies and renal pathology of Roquin san/san mice. Roquin san/san Sap Ϫ / Ϫ mice had not developed ANAs by 8 wk of age ( Fig. 5 a ) . Assessment of high-affi nity anti-dsDNA IgG antibodies at 6 mo of age (by immunofl uorescence using Crithidia luciliae substrate) revealed positive dsDNA antibodies in all Roquin san/san mice evaluated, whereas only one out of six Roquin san/san Sap Ϫ / Ϫ mice had detectable antibodies. Renal histology revealed that Roquin san/san Sap Ϫ / Ϫ mice had only minor interstitial nephritis and thickening of the mesangial matrix, with no detection of immune complex deposition observed by electron microscopy ( Fig. 5, b and c ) . These data suggest that abrogation of signaling through SAP greatly reduced the autoimmune manifestations of Roquin san/san mice. In contrast, SAP defi ciency conferred no signifi cant reduction of splenomegaly, lymphadenopathy, and hypergammaglobulinemia present in Roquin san/san mice, indicating that these defects are not mediated by excessive T FH cell formation and GC function (Fig. S3, a - Adoptively transferred SW HEL B cells formed HEL-specifi c GCs in all four cohorts. Signifi cantly fewer GCs were observed in Sap Ϫ / Ϫ than in wild-type mice (23,958 ± 15,920 vs. 1,186 ± 1,019; P = 0.005; Fig. 5 d ) , confi rming a B cell -extrinsic contribution of SAP to the GC response ( 34, 36, 38 ) . In addition, SAP defi ciency corrected the extreme GC formation observed in Roquin san/san mice (124,528 ± 25,980 vs. 30,528 ± 18,100; P = 0.0004) to a response of similar magnitude to Roquin +/+ mice ( Fig. 5 a ) . This suggests that the SAP-mediated eff ect in Roquin san/san mice is also caused by B cell -extrinsic factors, and is most likely caused by SAP ' s regulation of T FH cells.
To determine whether the loss of Sap in Roquin san/san mice selectively aff ected the GC response or also impaired the extrafollicular response, we identifi ed donor-derived extrafollicular plasma cells containing intracellular anti-HEL Ig at day 5 after immunization ( Fig. 5 e ) . At this time point, GC-derived plasma cells cannot be detected ( 41 ( Fig. 5 e ) . These data suggest that the reduction of the GCs in Roquin san/san mice caused by Sap defi ciency is mainly a result of B cell -extrinsic factors, and that this results in selective inhibition of the GC pathway.
Roquin san/san Sap ؊ / ؊ mice have reduced expression of ICOS and IL- 21 We have demonstrated that Roquin san/san Sap Ϫ / Ϫ mice have fewer T FH cells, a correction of the spontaneous GC response, and a reduction in autoimmune pathology. To gain insight into the possible functional T FH defect brought about by SAP defi ciency in Roquin san/san mice, we quantifi ed the changes in the expression of ICOS and IL-21, both of which are increased in Roquin san/san CD4 + cells ( 22 ) and are shown to be essential for T FH cell formation, homeostasis, and function ( 33, 34, 42, 43 ) . Loss of SAP reduced the levels of ICOS on both naive (CD44 low ) and activated/memory (CD44 high ) CD4 + T cells in Roquin san/san mice and to an even greater extent on Roquin +/+ mice ( Fig. 6, a -c ( Fig. 6 d ) . Remarkably, the levels of IL-21 found in Roquin san/san Sap Ϫ / Ϫ cultures were comparable to those of wild-type ( Roquin +/+ Sap +/+ ) mice. As previously reported ( 37 ) , SAP defi ciency resulted in higher CD40L expression upon activation in both Roquin +/+ and Roquin san/san mice ( Fig. 6, e and f ) .
IL-21 defi ciency does not prevent autoimmunity in Roquin san/san mice
Given that Roquin san/san mice produce high levels of IL-21 and given the recently described role for IL-21 in T FH cell generation after immunization ( 33, 34 ), we investigated whether IL-21 also controls autoantibody production, T FH cell accumulation, and spontaneous GC formation in these mice. To this end, we crossed Roquin san/san mice to IL-21 Ϫ / Ϫ mice on a C57BL/6 background and assessed ANA formation. There was no diff erence in the pattern or titer of ANAs produced by 10-wk-old Roquin san/san IL-21 +/+ and Roquin san/san IL-21 Ϫ / Ϫ mice ( Fig. 7, a and b ) . Overall, IL-21 defi ciency did not aff ect the hypergammaglobulinemia of Roquin san/san mice ( Fig. 7 c ) , and consistent with previous reports ( 44 ), IgG1 titers were reduced, whereas IgE titers were increased ( Fig. 7 c ) . Likewise, loss of IL-21 did not correct the lymphadenopathy or the splenomegaly of Roquin san/san mice ( Fig. 7 d ) .
We then investigated whether IL-21 infl uences T FH cell accumulation and spontaneous GC formation. There was no diff erence in either the number of T FH cells or GC cells between Roquin san/san IL-21 +/+ and Roquin san/san IL-21 Ϫ / Ϫ littermates, ( Fig. 7, e and f ) . These data suggest that IL-21 does not play a role in spontaneous GC formation, T FH development, or accumulation in Roquin san/san mice.
DISCUSSION
Elucidation of the defect that results in high-affi nity antibodies to dsDNA is central to understanding lupus and, hence, the development of specifi c therapeutic interventions. In the Roquin san/san model, a fundamental GC defect results in the production of autoantibodies. This pathway appears to be critical for disease development, because an impediment to GC formation conferred by halving the dose of Bcl6 is sufficient to attenuate the lupus phenotype. Our data are consistent with other evidence that aberrant T cell help can cause spontaneous GC formation and autoimmunity ( 9, 45 ) . We show the expanded T FH cell subset, a consistent component of the Roquin san/san phenotype, is responsible for excessive GC formation. In Roquin san/san mice, GCs form in the absence of foreign antigen and yield ANAs. SAP defi ciency reduces the size and activity of the T FH subset and abrogates autoantibody production and renal disease. These fi ndings provide the in vivo cellular mechanism to link the defect in microRNA (miRNA)-mediated repression of T FH molecules conferred by the san allele of Roquin with the lupus phenotype of Roquin san/san mice ( 22, 28 ) . Moreover, they elucidate a mechanism of lupus that could be generalized to other defects of T FH homeostasis. Importantly, they provide evidence that defects in positive selection of GC B cells can cause autoimmunity.
In this paper, we demonstrate that Roquin san/san acts T cell intrinsically to drive an accumulation of T FH cells that support a spontaneous GC response. Overexpression of ICOS is a plausible mechanism, because ICOS is important for the generation and survival of T FH cells ( 34, 42, 43 ) , and Roquin normally acts to repress Icos miRNA ( 28 ) . Previously, we have shown that this accounts for the lymphoproliferation, splenomegaly, and lymphadenopathy of Roquin san/san mice ( 28 ) . The data presented in this paper also show that CD28 signaling is a key contributor to the development of systemic autoimmunity in Roquin san/san mice. CD28 is not only expressed on CD4 + cells, but it has also been found to be expressed by stromal cells ( 46 ) and plasma cells ( 47 ) , and this expression can infl uence B cell development and antibody responses. Nevertheless, our previous data showing that the increased plasma cell and GC numbers, and B cell activation in sanroque are predominantly B cell extrinsic ( 22 ) , together with the potent eff ects of SAP deficiency in the sanroque autoimmune phenotype, suggest that CD28 defi ciency in T cells rather than in B cells or stromal cells is responsible for the observed eff ect. Thus, we infer that the sanroque lupus phenotype is T cell mediated. CD28 defi ciency considerably decreased the abnormally high levels of ICOS normally found on Roquin san/san T cells. This is likely to contribute causes a lymphoproliferative syndrome, danger signals may also be required for the production of autoantibodies that cause endorgan damage. This is because ligands for CD28 are dependent to the abrogation of the lupus phenotype in a manner comparable to halving the gene dose of Icos ( 28 ) . A nonmutually exclusive explanation is that although ICOS overexpression immunity in these mice. Finally, although sanroque SAP-deficient mice do not form spontaneous GCs, they still show hypergammaglobulinemia and very mild cell infi ltrates in the kidney, suggesting that a non-T FH -mediated pathway contributes to these manifestations in Roquin san/san mice.
Our data add to previous studies demonstrating that SAP defi ciency acts B cell extrinsically, causing a profound and selective impairment of GC reactions ( 37 ) with little eff ect on extrafollicular plasma cell generation. The requirement for SAP for eff ective T FH cell function has previously been ascribed to dysregulated kinetics of ICOS up-regulation and increased expression of CD40L ( 37 ), which we confi rmed in the present study. Our work also shows that SAP signaling is required to maintain elevated baseline levels of ICOS in naive sanroque T cells.
An intriguing fi nding of this study was the lack of any role for IL-21 in Roquin san -induced lupus, T FH cell accumulation, and spontaneous GC formation. Although recent reports have shown that IL-21 is involved in T FH cell generation and optimal GC responses ( 33, 34 ) , other groups have previously reported normal GC formation with an accumulation in IgG memory B cells in IL-21R Ϫ / Ϫ mice ( 54 ) . A recent paper has also shown that IL-21 can be produced by extrafollicular T cells, which contribute to autoimmunity in MRL lpr mice ( 55 ) . Furthermore, IL-21 has been shown to potently induce plasma cell generation from naive B cells ( 56 ) , suggesting an important role for IL-21 in extrafollicular B cell responses. Even if IL-21 turns out to be critical for GC B cell selection, it is possible that other molecules overexpressed by sanroque T FH cells, such as ICOS, substitute for the eff ects normally mediated by IL-21.
The pathway to systemic autoimmunity identifi ed in this paper highlights the importance of negative selection of self-reactive lymphocytes in GCs. Autoreactive B cells are a normal component of the naive peripheral B cell repertoire. In lupus patients, these cells enter GCs, whereas in healthy individuals, they are excluded ( 57 ) . Other evidence indicates that in lupus, GCs can generate B cells that have antinuclear specifi cities from nonautoreactive precursors ( 7 ) . Furthermore, GCs are increased in lupus ( 58 ) . Regardless of their ontogeny, autoreactive centrocytes would normally fail to receive selection signals by T FH cells and would undergo apoptosis ( 59 ) . Our data suggest that this process is perturbed by the san allele of Roquin .
According to the prevailing model for T FH selection of centrocytes, large numbers of GC B cells compete with each other for the limiting available T cell help ( 60 ) and for antigen on follicular dendritic cells. Centrocytes that have acquired higher affi nity for antigen would scavenge more antigen from follicular dendritic cells, which would confer on them an avidity advantage in interactions with T FH cells compared with lower affi nity B cells. Based on this model, we speculate that in Roquin san/san mice, competition by B cells for T cell help is reduced by the expansion of T FH cells. Interactions between centrocytes and T FH cells are determined by affi nity for MHC-peptide for the TCR modifi ed by the action of accessory molecules. Loss of SAP in Roquin san/san mice causes a reduction in ICOS overexpression, potentially increasing the on Toll-like receptor ligation, which typically occurs during infections and tissue damage, and potentially after apoptosis. Because mice in this study were housed under specifi c pathogen-free conditions, one explanation for the source of the danger signal in the san/san model might be the abundance of apoptotic cells in GCs, which overloads the normal nonimmunogenic modes of disposal ( 11 ) . Apoptotic cells display self-antigens that are the target of the autoimmune response in lupus, and are ligands for TLR7 and/or TLR9 on antigen-presenting cells and/or B cells ( 48 ) .
Our data indicate that the GC is central to the autoimmune phenotype of Roquin san/san mice, because reduction of spontaneous GCs, conferred by halving the gene dose of the transcriptional regulator Bcl6 , results in a proportionate amelioration of autoimmune pathology. This heterozygote phenotype is a novel fi nding. Although previous reports describe intact antibody responses in Bcl6 +/ Ϫ mice on day 11 after immunization ( 26 ) , these are likely to derive predominantly from the extrafollicular response at this early time point. The heterozygote phenotype is consistent with the observation that GC diff erentiation is accompanied by only a twofold increase in Bcl6 miRNA expression ( 49 ) . Although our work does not exclude an eff ect of halving the gene dose of Bcl6 on T FH cell formation, it does strongly suggest that the GC reduction seen in Bcl6 +/ Ϫ mice is a consequence of reduced B cell -expressed BCL6: in 50% Bcl6 +/+ /50% Bcl6 +/ Ϫ mixed bone marrow chimeras, GC B cells were only decreased in GC B cells deriving from Bcl6 +/ Ϫ bone marrow. Furthermore, transfer of Bcl6 +/+ SW HEL B cells into Bcl6 +/ Ϫ recipient mice, providing the major source of T FH cells, resulted in normal donor-derived GC numbers after HEL-SRBC immunization.
SAP defi ciency abrogates autoimmunity in Roquin san/san mice. SAP defi ciency aff ects several T cell subsets and natural killer cells ( 50, 51 ) but profoundly impairs the ability of T cells to provide help to B cells for GC formation ( 37 -39 ) . Our results demonstrate that SAP defi ciency specifi cally reduces the development of CD4 + T cells with a T FH phenotype, leaving Th1 and Th2 cell formation largely intact. This, together with the evidence presented for the GC dependence of autoimmunity, as well as the observation that transfer of Roquin san/san T FH cells induces spontaneous GC, places aberrant expansion of T FH cells at the root of spontaneous GC formation and autoimmunity in Roquin san/san mice. This mechanism is consistent with another lupus model, B6.Sle1 yaa , in which T cells have a transcriptional profi le typical of T FH cells ( 21 ) .
SAP defi ciency has been shown to ameliorate autoimmunity in another lupus-prone strain, MRL lpr mice ( 52 ). These mice have been shown to also develop spontaneous GCs ( 9 ), although SHM of autoreactive B blasts has been shown to occur in the T zone areas rather than within GCs ( 16 ) . SAP defi ciency has been shown to eliminate the pathogenic CD4 Ϫ CD8 Ϫ T cells that account for the lymphadenopathy of MRL lpr mice ( 52 ) , and there is evidence that autoimmunity in MRL lpr mice is T cell dependent ( 53 ) . It will be interesting to examine whether dysregulated ectopically located T FH cells or an extrafollicular counterpart is contributing to auto-those that regulate IL-21, ICOS, or ICOSL expression, could contribute to lupus pathogenesis. Because T FH cells are present in peripheral blood, this is a testable hypothesis. Indeed, there is evidence that SLE patients have increased numbers of circulating CD4 + ICOS + cells in their peripheral blood compared with nonautoimmune individuals ( 62 ) . Because T FH cells are antigen affi nity required to reach the T FH activation threshold in Roquin san/san Sap Ϫ / Ϫ mice.
Although the lupus phenotype of Roquin san/san mice is Mendelian, apart from rare exceptions ( 61 ), lupus is a polygenic disorder. Nevertheless, it is plausible that one or more polymorphisms or mutations that aff ect T FH homeostasis, such as the cells expressing the highest levels of ICOS ( 63, 64 ) , it is possible that circulating CD4 + ICOS + cells refl ect an excessive T FH response, and is consistent with recent data showing that a subset of SLE patients have an increased proportion of CD4 + C D45RO + CXCR5 + ICOS high PD-1 high cells in their peripheral blood (a phenotype that correlates with higher titers of antidsDNA antibodies and more severe kidney damage; unpublished data). If confi rmed in independent studies, the GC -T FH pathway elucidated in the Roquin san/san model pathway would emerge as a novel and specifi c target for therapy. housed in specifi c pathogen-free conditions at the Australian National University Bioscience Facility. IL-21 KO mice were generated at Lexicon Pharmaceuticals, Inc. and were provided by M. Smyth (Peter MacCallum Cancer
MATERIALS AND METHODS
Mice and immunizations.
Roquin san/san and C57BL/6 (B6) mice, all crossed to Sap Ϫ / Ϫ , Bcl6 +/ Ϫ , Cd28 Ϫ / Ϫ , and IL-21 Ϫ / Ϫ mice, and SW HEL mice, were In e and f, the numbers in the plots represent percentages.
were applied in quadruplicate, and IL-21 concentration was determined with 200 ng/ml of HRP-conjugated goat anti -mouse IL-21 IgG (R & D systems). Bound IL-21 was detected using phosphatase substrate tablets (Sigma-Aldrich). Plates were read at 405 nm using a microplate reader (Thermomax; MDS Analytical Technologies). The titers for supernatant samples were calculated according to the standard curve generated using twofold dilutions of recombinant mouse IL-21 (500-15 pg/ml; R & D Systems) and Prism software (GraphPad Software, Inc.). IL-17 ELISA was performed using the mouse IL-17A ELISA Ready-Set-Go! Kit (eBioscience) according to the manufacturer ' s instructions.
For analysis of total IgG, IgG1, and IgE titers, Maxisorb plates were coated with goat anti -mouse light chain or anti -mouse IgE (BD). Serial serum dilutions were applied, and Ig concentration was determined with HRP-conjugated goat anti -mouse IgG, IgG1 (SouthernBiotech), or biotinlyated IgE (BD), followed by streptavidin-HRP. The enzyme bound to plates was developed using phosphatase substrate tablets. Plates were read at 405 nm using a Thermomax microplate reader. The titers for serum samples were calculated as the log serum concentration required to achieve 50% maximum OD.
Immunohistochemistry. 5-μ m acetone-fi xed frozen sections of spleen were air dried and washed in 0.1 M Tris-buff ered saline (TBS), pH 7.6, and were stained with various antibodies for 45 min at room temperature in a moist chamber. After a further wash in TBS, secondary reagents, previously absorbed in 10% normal mouse serum, were added to the sections for 45 min. Where biotin-conjugated primary or secondary reagents were used, streptavidin alkaline phosphatase (Vector Laboratories) was added after a further wash in TBS and incubated for 20 min. HRP activity was detected using diaminobenzidine tetrahydrochloride solution (Sigma-Aldrich) and hydrogen peroxide. Alkaline phosphatase activity was detected using the AP Substrate Kit III (Vector Laboratories). Sections were mounted with IMMU-MOUNT (Thermo Shandon) and viewed under a microscope (model IX71; Olympus).
Renal pathology. Kidneys were fi xed in 10% neutral buff ered formalin. 4-μ m paraffi n-embedded sections were dewaxed and stained with hematoxylin and eosin (H & E) and silver stains. For electron microscopy, kidneys were fi xed in 2% glutaraldehyde in 0.1 M cacodylate buff er, pH 7.4, at room temperature overnight. They were then washed in 0.1 M cacodylate buff er, treated with 0.2 mm of fi ltered 2% osmium tetroxide in 0.1 M cacodylate buff er, pH 7.4, at room temperature for 2 h, and washed in double-distilled H 2 O. Samples were stained with 0.2 mm of fi ltered 2% aqueous uranyl acetate for 30 min at room temperature, dehydrated in ethanol, and embedded in 100% TAAB medium mix, low viscosity resin. They were then mounted in orientation silicone molds and heated in an oven at 70 ° C for 8 -12 h. The samples were examined on a transmission electron microscope (model 1011; JEOL) at 60 KeV. The images were captured using a digital camera (MegaView III) and the AnalySIS software package (Soft Imaging System; Olympus), and were subsequently scored using the criteria detailed in Table S1 (available at http://www.jem.org/cgi/content/full/jem.20081886/DC1).
ANA and dsDNA assessment. Serum obtained by eye bleed from 8-wkold mice was diluted in PBS 1:40 and used for indirect immunofl uorescence on fi xed Hep-2 slides (Antibodies, Inc.) for ANA detection, and serum from 6-mo-old mice was diluted 1:20 and used for indirect immunofl uorescence on fi xed C. luciliae slides (Antibodies, Inc.) for ANA anti-dsDNA antibody detection, respectively. Alexa Fluor 488 goat anti -mouse IgG (Invitrogen) was used to detect mouse antibodies. Autoantibodies were scored blind as negative or positive on a scale of 1 -3 based on the intensity of fl uorescence. Relative levels of ANAs were estimated by viewing the slides using a confocal microscope (TCS SP5; Leica) at 20 × magnifi cation and a fi xed laser power, and measuring the fl uorescence of fi ve randomly selected 1,250-μ m 2 regions of Hep2 cells, compared with fi ve regions where cells were absent. The sample-specifi c mean background was subtracted from the sample-specifi c mean fl uorescence to give an estimation of fl uorescent intensity. These results concurred with a blinded manual scoring of fl uorescence for the same samples.
Statistical analysis. Data were analyzed using a two-tailed Student ' s t test using Prism software.
Centre, Melbourne, Australia) and ZymoGenetics, Inc. These mice were backcrossed 10 generations onto the C57BL/6 background. SW HEL mice carry a Vk10-light chain transgene and a knocked in VH10 Ig heavy chain in place of the JH segments of the endogenous IgH gene that encode a high-affi nity antibody for HEL ( 65 ) . All animal procedures were approved by the Australian National University Animal Ethics and Experimentation Committee.
To generate thymus-dependent responses where indicated in the fi gures, 8 -12-wk-old mice were immunized i.p. with 2 × 10 9 SRBCs (Institute of Medical and Veterinary Science Veterinary Services). For experiments involving SW HEL mice, 10 4 SW HEL B cells were transferred into recipients, which were simultaneously immunized i.v. with 2 × 10 8 SRBCs conjugated with mutant HEL 2x using a protein conjugation kit (Invitrogen) ( 41 ) .
Bone marrow chimeras. Recipient C57BL/6-Ly5a mice were sublethally irradiated with 1,000 Rad and were reconstituted via i.v. injection with 2 × 10 6 donor bone marrow -derived hematopoetic stem cells.
Antibodies. Antibodies and streptavidin conjugates for fl ow cytometry were from BD unless otherwise indicated: anti -mouse B220-PerCP, CD4-PerCP, ICOS-PE (eBioscience), FoxP3 (eBioscience), GL-7 -FITC, GATA3-allophycocyanin, Tbet -PerCP Cy5.5, CD95-PE, CXCR5-biotin, PD-1 -PE (eBioscience), CTLA-4 -PE, CD25-allophycocyanin, streptavidin -PerCP Cy5.5, and CD40L-biotin. For immunohistochemistry, the primary antibodies and reagents used were rat anti -mouse IgD (SouthernBiotech), biotinylated anti -mouse TCR ␤ (BD), rat anti -mouse PD-1 (BioLegend), and PNA-biotin (Vector Laboratories); the secondary antibody used was rabbit anti -rat horseradish peroxidase (HRP; Dako).
Cell isolation, culture, and stimulation. Single-cell suspensions were prepared from spleens of unimmunized and/or immunized mice. Single-cell suspensions were prepared in RPMI 1640 medium (JRH Biosciences) supplemented with 2 mM l-Glutamine (Invitrogen), 100 U penicillin-streptomycin (Invitrogen), 0.1 mM nonessential amino acids (Invitrogen), 100 mM Hepes (Sigma-Aldrich), 5 × 10 Ϫ 5 2-mercaptoethanol, and 10% fetal calf serum by sieving and gentle pipetting through 70-μ m nylon mesh fi lters (Falcon; BD). Cells were then cultured for 24 h at 37 ° C/5% CO 2 with 50 ng/ml PMA (Sigma-Aldrich) and 1 μ M ionomycin (Sigma-Aldrich) in triplicate wells. Cell culture supernatants were aspirated for further analysis by ELISA. For CD40L expression, cells were cultured in triplicate wells for 5 h in 96-well plates (Costar; Corning) with platebound 1 μ g/ml anti-CD3 (BD) and 10 μ g/ml anti-CD28 (BD). Biotinylated anti-CD40L antibody was added 2 h before harvesting.
Flow cytometry. For surface staining, single-cell suspensions were prepared as described in the previous section, and cells were maintained in the dark at 4 ° C throughout. Cells were washed twice in ice-cold FACS buff er (2% fetal calf serum, 0.1% NaN 3 in PBS), and incubated with each antibody and conjugate layer for 30 min and washed thoroughly with FACS buff er between each layer. Intracellular staining was performed using the Cytofi x/ Cytoperm kit (BD) according to the manufacturer ' s instructions. For detection of HEL-binding B cells, HEL was conjugated to Alexa Fluor 647 using the manufacturer ' s instructions (Invitrogen). A FACSCalibur (BD) with CellQuest software (BD) was used for the acquisition of fl ow cytometric data, and FlowJo software (Tree Star, Inc.) was used for analysis.
Adoptive cell transfer experiments. T FH cells (CD4 + CD44 high PD-1 high CX-CR5 high ) and non-T FH eff ector cells (CD4 + CD44 high PD-1 int/lo CXCR5 Ϫ ) from spleens and lymph nodes were prepared and stained as described in the previous paragraph and sorted on a FACSAria (BD). 5 × 10 6 sorted cells were resuspended in PBS and injected into the tail vein of unmanipulated CD45.1 C57BL/6 recipients. 3-wk after transfer, splenic donor (CD45.2) T FH cells and host GC cells were enumerated by fl ow cytometry. 
